Hualan Biological Engineering Inc. (SHE:002007)

China · Delayed Price · Currency is CNY

14.29

+0.09 (0.63%)

Mar 24, 2026, 1:15 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Blood Product	3.25B	2.93B	2.68B	2.60B	2.59B
Blood Product Growth	10.91%	9.22%	3.14%	0.25%	-1.99%
Vaccine Product	1.12B	2.40B	1.82B	1.82B	2.42B
Vaccine Product Growth	-53.54%	32.30%	-0.38%	-24.63%	132.07%
Others	16.34M	10.89M	20.21M	13.86M	11.08M
Others Growth	50.09%	-46.11%	45.75%	25.08%	-14.23%
Total	4.38B	5.34B	4.52B	4.44B	5.02B
Total Growth	-18.02%	18.26%	1.82%	-11.69%	35.76%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	4.38B	5.33B	4.50B	4.43B	5.02B
China Growth	-17.83%	18.40%	1.58%	-11.82%	35.79%
Foreign	1.73M	14.73M	17.81M	6.92M	-
Foreign Growth	-88.27%	-17.33%	157.52%	-	-
Total	4.38B	5.34B	4.52B	4.44B	5.02B
Total Growth	-18.02%	18.26%	1.82%	-11.69%	35.76%

Source: S&P Global Market Intelligence.